Vera Therapeutics, Inc. Investment Income, Interest
Vera Therapeutics, Inc. (VERA) reported Investment Income, Interest of $5.35 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-10
- Vera Therapeutics, Inc. investment income, interest for the quarter ending 2026-06-30 was $5.35M, a 15.38% decline year-over-year.
- Vera Therapeutics, Inc. investment income, interest for the quarter ending 2026-03-31 was $6.36M, a 7.98% decline year-over-year.
- Vera Therapeutics, Inc. investment income, interest for the quarter ending 2025-12-31 was $5.52M, a 17.20% decline year-over-year.
- Vera Therapeutics, Inc. investment income, interest for the quarter ending 2025-09-30 was $5.74M, a 20.48% increase year-over-year.
- Vera Therapeutics, Inc. investment income, interest for fiscal 2025 was $24.48M, a 18.18% increase from fiscal 2024.
- Vera Therapeutics, Inc. investment income, interest for fiscal 2024 was $20.71M, a 159.61% increase from fiscal 2023.
- Vera Therapeutics, Inc. investment income, interest for fiscal 2023 was $7.98M, a 355.94% increase from fiscal 2022.
- Vera Therapeutics, Inc. investment income, interest for fiscal 2022 was $1.75M, a 11566.67% increase from fiscal 2021.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $5.35M 10-Q · filed 2026-08-10 | $11.70M 10-Q · filed 2026-08-10 | $17.22M derived: sum of 3 quarters · filed 2026-08-10 | $22.96M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $6.36M 10-Q · filed 2026-05-07 | $11.87M derived: sum of 2 quarters · filed 2026-05-07 | $17.61M derived: sum of 3 quarters · filed 2026-05-07 | $23.93M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $5.52M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $11.25M derived: sum of 2 quarters · filed 2026-02-26 | $17.57M derived: sum of 3 quarters · filed 2026-08-10 | $24.48M 10-K · filed 2026-02-26 |
| 2025-09-30 | $5.74M 10-Q · filed 2025-11-05 | $12.06M derived: sum of 2 quarters · filed 2026-08-10 | $18.96M 10-Q · filed 2025-11-05 | $25.63M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $6.32M 10-Q · filed 2026-08-10 | $13.23M 10-Q · filed 2026-08-10 | $19.89M derived: sum of 3 quarters · filed 2026-08-10 | $24.65M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $6.91M 10-Q · filed 2026-05-07 | $13.57M derived: sum of 2 quarters · filed 2026-05-07 | $18.33M derived: sum of 3 quarters · filed 2026-05-07 | $23.43M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $6.66M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $11.42M derived: sum of 2 quarters · filed 2026-02-26 | $16.53M derived: sum of 3 quarters · filed 2026-02-26 | $20.71M 10-K · filed 2026-02-26 |
| 2024-09-30 | $4.76M 10-Q · filed 2025-11-05 | $9.87M derived: sum of 2 quarters · filed 2025-11-05 | $14.05M 10-Q · filed 2025-11-05 | $16.01M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $5.10M 10-Q · filed 2025-08-05 | $9.29M 10-Q · filed 2025-08-05 | $11.25M derived: sum of 3 quarters · filed 2026-02-26 | $13.41M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $4.19M 10-Q · filed 2025-05-07 | $6.15M derived: sum of 2 quarters · filed 2026-02-26 | $8.30M derived: sum of 3 quarters · filed 2026-02-26 | $10.54M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $1.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $4.12M derived: sum of 2 quarters · filed 2026-02-26 | $6.36M derived: sum of 3 quarters · filed 2026-02-26 | $7.98M 10-K · filed 2026-02-26 |
| 2023-09-30 | $2.16M 10-Q · filed 2024-11-07 | $4.40M derived: sum of 2 quarters · filed 2024-11-07 | $6.02M 10-Q · filed 2024-11-07 | $6.91M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $2.24M 10-Q · filed 2024-08-08 | $3.86M 10-Q · filed 2024-08-08 | $4.76M derived: sum of 3 quarters · filed 2024-08-08 | $5.32M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $1.62M 10-Q · filed 2024-05-10 | $2.52M derived: sum of 2 quarters · filed 2024-05-10 | $3.08M derived: sum of 3 quarters · filed 2024-05-10 | $3.35M derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $894.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $1.46M derived: sum of 2 quarters · filed 2024-03-27 | $1.72M derived: sum of 3 quarters · filed 2024-03-27 | $1.75M 10-K · filed 2024-03-27 |
| 2022-09-30 | $567.00K 10-Q · filed 2023-11-09 | $830.00K derived: sum of 2 quarters · filed 2023-11-09 | $856.00K 10-Q · filed 2023-11-09 | $862.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $263.00K 10-Q · filed 2023-08-10 | $289.00K 10-Q · filed 2023-08-10 | $295.00K derived: sum of 3 quarters · filed 2023-08-10 | $300.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $26.00K 10-Q · filed 2023-05-11 | $32.00K derived: sum of 2 quarters · filed 2023-05-11 | $37.00K derived: sum of 3 quarters · filed 2023-05-11 | $39.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $11.00K derived: sum of 2 quarters · filed 2023-03-28 | $13.00K derived: sum of 3 quarters · filed 2023-03-28 | $15.00K 10-K · filed 2023-03-28 |
| 2021-09-30 | $5.00K 10-Q · filed 2022-11-09 | $7.00K derived: sum of 2 quarters · filed 2022-11-09 | $9.00K 10-Q · filed 2022-11-09 | $11.00K derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $2.00K 10-Q · filed 2022-08-10 | $4.00K 10-Q · filed 2022-08-10 | $6.00K derived: sum of 3 quarters · filed 2022-08-10 | $6.00K derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | $2.00K 10-Q · filed 2022-05-16 | $4.00K derived: sum of 2 quarters · filed 2022-05-16 | $4.00K derived: sum of 3 quarters · filed 2022-05-16 | $4.00K derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $2.00K derived: sum of 2 quarters · filed 2022-03-28 | $2.00K derived: sum of 3 quarters · filed 2022-03-28 | $8.00K 10-K · filed 2022-03-28 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $0.00 derived: sum of 2 quarters · filed 2021-11-10 | $6.00K 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-16 | $6.00K 10-Q · filed 2021-08-16 | ||
| 2020-03-31 | $6.00K 10-Q · filed 2021-06-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |